Skip to main content
Clinical Trials/NL-OMON41499
NL-OMON41499
Completed
Not Applicable

DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents. A prospective, randomized, controlled, triple-blind, multi-center trial comparing PTFE-covered balloon-expandable stents versus uncovered balloon-expandable stents in patients with advanced occlusive disease of the common iliac artery in terms of morphologic, clinical, and hemodynamic outcome after a 2-year follow-up. - Covered versus uncovered balloon-expandable iliac stents.

Maasstadziekenhuis0 sites174 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
arteriosclerosis of the leg
Sponsor
Maasstadziekenhuis
Enrollment
174
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Maasstadziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- Age over 18
  • \- Symptomatic, atherosclerotic lesion of the common iliac artery, either a hemodynamically significant stenosis with a length of more than 3 cm, or an occlusion
  • \- Signed informed consent form

Exclusion Criteria

  • \- Stenosis with a length of less than 3 cm
  • \- Presence of a metastatic malignancy, or other disease that limits life expectancy to less than two years.
  • \- Previous endovascular or surgical treatment of the common iliac artery on the affected side.
  • \- Inability or unwillingness to comply with the follow\-up schedule.
  • \- Mental disability or language barrier that hinders the ability to understand and comply with the informed consent.
  • \- Pregnancy or breast\-feeding.
  • \- Severe renal failure (e\-GFR \<30 mL/min/1\.73 m2\)
  • \- Known allergy to iodinated contrast agents or to PTFE.
  • \- Contra\-indication for anti\-coagulation.
  • \- Acute limb ischemia

Outcomes

Primary Outcomes

Not specified

Similar Trials